About this episode

Dr. Ruchi Talwar interviews Dr. Kirsten Greene about the role of pelvic lymph node dissection in prostate cancer surgery and the impact of PSMA PET imaging on surgical decisions.

Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology, Dr. Ruchi Talwar interviews Dr. Kirsten Greene about how advanced imaging is influencing decisions for radical prostatectomy. They examine the strengths and limits of PSMA PET, the risks and benefits of PLND, and why careful, evidence-based decision-making remains essential. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction03:12 - Risk Calculators and Consent04:39 - Nomograms vs. Complications09:57 - Endpoints That Matter11:38 - PSMA PET Strengths and Limits13:51 - Negative PET Decision-Making15:08 - Positive PET and Multimodal Care18:02 - Fluorescence Guided Surgery19:10 - Counseling on Complications22:27 - Preventing Lymphocele24:56 - How Lahey Wrap Works26:45 - Future Mapping and Therapy28:47 - Research Gaps and Dogma31:07 - Key Pearls and Wrap Up --- More about this episode Dr. Greene explains her approach using MSK and Briganti nomograms alongside PSMA PET, noting that PET scans may miss small nodal disease and quality varies between centers. She emphasizes PLND as a staging tool rather than a curative procedure…

People in this episode

Host: Dr. Ruchi Talwar

Guest: Dr. Kirsten Greene

Topics covered

• pelvic lymph node dissection
• prostate cancer surgery
• PSMA PET imaging
• evidence-based decision-making
• surgical techniques
• multimodal care

Keywords

• pelvic lymph node dissection
• prostate cancer
• PSMA PET
• surgical complications
• evidence-based medicine

Mentioned in this episode

Organizations: BackTable

More episodes of BackTable Urology

• Ep. 318 Exploring Neuromodulation: Sacral vs Tibial Approaches with Dr. Ken Peters and Dr. Tracey Wilson · July 21, 2026 · 1h 0m
• Ep. 317 Focal Therapy in Prostate Cancer Treatment with Dr. George R. Schade · July 16, 2026 · 48 min
• Ep. 316 Bladder Cancer in the Community: Meeting Patients Where They Are with Dr. Adam J. Gadzinski · July 14, 2026 · 49 min
• Ep. 315 Private Equity's Impact on Urology Practices with Dr. Benjamin Lowentritt · July 10, 2026 · 49 min
• Ep. 314 Exploring PARP Inhibitor Combinations in Prostate Cancer with Dr. Rana McKay and Dr. Emmanuel Antonarakis · July 7, 2026 · 52 min
• Ep. 312 Managing Intravesical Therapy Toxicities in Bladder Cancer with Dr. Meredith Donahue and Mary Dunn, NP · June 25, 2026 · 31 min

Explore listener stats, chart rankings, contacts and more on the BackTable Urology podcast page.